Ductal carcinoma in situ--management update.
This ninth article in our series on breast disease will focus on ductal carcinoma in situ of the breast--a proliferation of potentially malignant cells within the lumen of the ductal system. An overview of the management of ductal carcinoma in situ including pathology, clinical presentation and relevant investigations is presented, and the roles and dilemmas of surgery, radiotherapy and endocrine therapy are discussed.
Stuart
Kirsty
K
NSW BReast Cancer Institute, Westmead Hospital, New South Wales.
Boyages
John
J
Brennan
Meagan
M
Ung
Owen
O
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002114:Calcinosis / Q000000981:diagnostic imaging; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008327:Mammography; D008408:Mastectomy / Q000379:methods; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D011878:Radiotherapy / Q000379:methods
D018931:Antineoplastic Agents, Hormonal